Uncategorized
AMA calls for more transparent prescription costs
In response to the recent spike of many prescription drug prices, the AMA adopted several policies to provide patients with more information about the drugs that they are prescribed and a rationale for price increases at its 2017 annual meeting, according to a press release. “Taken together, these policies would bring much needed transparency to drug pricing and provide a clear benefit to consumers struggling with exorbitant costs,” Barbara L. McAneny, MD, AMA President-elect, said in the release. “There seems to be no logic — or warning — to these (Read more...)